Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Cequent Seeks First Oral RNAi Trial Luke Timmerman 11/12/09 Boston
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target Luke Timmerman 11/11/09 Boston
RXi Replaces CEO Luke Timmerman 11/06/09 Boston
Cequent Pharmaceuticals, With First Oral RNAi Drug Soon to Enter Humans, Raises $3.4M Luke Timmerman 10/30/09 Boston
Why Big Pharma Wants To Be Like Big Biotech Stewart Lyman 08/19/09 National
Alnylam, Tekmira and New Northwest Firm, AlCana, Push Boundaries of RNAi Delivery Luke Timmerman 08/13/09 Boston
Alnylam Takes Moment to Pause on Cutting Edge, Mull Options on RSV Game Plan Luke Timmerman 08/11/09 Boston
Microsoft Sells Razorfish, EnerG2 Scores Stimulus Funds, Tekmira Teams Up with Alnylam, & More Seattle-Area Deals News Gregory T. Huang 08/11/09 Seattle
RXi Announces $8.3M Offering Wade Roush 07/31/09 Boston
RXI Licenses RNAi Delivery Mode Luke Timmerman 07/27/09 Boston
Dicerna, Archemix Team Up to Make Souped Up RNAi Combo Drugs Luke Timmerman 07/21/09 Boston
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News Luke Timmerman 06/25/09 Seattle
Amazon Buys SnapTell, Madrona Backs Animoto, MDRNA Works Out Tech License, & More Seattle-Area Deals News Gregory T. Huang 06/23/09 Seattle
AVI Developing Swine Flu Drugs Luke Timmerman 06/22/09 Seattle
MDRNA Gains Full Rights to Drug Technology Luke Timmerman 06/19/09 Seattle
UW Stem Cell Startup is Born, Global Health’s “Davos” Arrives, MDRNA Unloads Debt, & More Seattle-Area Life Sciences News Luke Timmerman 06/18/09 Seattle
MDRNA Pays Off $5.5M Debt Luke Timmerman 06/16/09 Seattle
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News Luke Timmerman 06/11/09 Seattle
MDRNA Raises $10.5M Luke Timmerman 06/10/09 Seattle
MDRNA Nasal Spray Gets FDA Nod Luke Timmerman 06/09/09 Seattle
Aileron Snags $40M From Quartet of Pharma Giants to Develop New Class of Drugs Luke Timmerman 06/08/09 Boston
AVI Gets $3M For Muscular Dystrophy Luke Timmerman 06/04/09 Seattle
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News Luke Timmerman 05/28/09 Seattle
Tekmira Tackles RNAi Delivery Challenge, With Alnylam, Roche Putting It to the Test Luke Timmerman 05/26/09 Seattle
MDRNA Shrinks Board of Directors Luke Timmerman 05/21/09 Seattle
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News Luke Timmerman 05/14/09 Seattle
Tekmira Nabs $50M RNAi Deal Luke Timmerman 05/11/09 Seattle
AVI Wins Part of $2.5M Contract Luke Timmerman 05/06/09 Seattle
Oral RNAi Drug Stops Inflammation in Mice, RXi Says Luke Timmerman 04/30/09 Boston
Ebola Fighter AVI Biopharma Gears Up for Biodefense Contracts Luke Timmerman 04/29/09 Seattle
Page 1 of 3 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.